Research & Literature

Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients.

Lin W, Lu S, Chen H, et al.

Rheumatology (Oxford, England) 2015; (54(11)):1982-90 doi:10.1093/rheumatology/kev203.

Idiopathic retroperitoneal fibrosis: clinicopathologic features and outcome analysis.

Yachoui R, Sehgal R, Carmichael B

Clinical rheumatology 2016; (35(2)):401-7 doi:10.1007/s10067-015-3022-y.

IgG4-related Disease from Head to Toe.

Martínez-de-Alegría A, Baleato-González S, García-Figueiras R, et al.

Radiographics : a review publication of the Radiological Society of North America, Inc 2015; (35(7)):2007-25 doi:10.1148/rg.357150066.

[IgG4-Related Retroperitoneal fibrosis].

Fernández Regueiro R, Pérez García C, Fonseca Aizpuru EM, et al.

Archivos espanoles de urologia 2015; (68(10)):755-7.

IgG4-related retroperitoneal fibrosis: A case report and review of literature.

Niaz A, Ahmad AH, , et al.

JPMA. The Journal of the Pakistan Medical Association 2016; (66(2)):220-2.

Utility of FDG-PET/CT in the diagnosis of IgG4-related diseases.

Zhao Z, Wang Y, Guan Z, et al.

Clinical and experimental rheumatology 2016; (34(1)):119-25.

Clinical features and prognostic factors of ten patients with renal failure caused by IgG4-related retroperitoneal fibrosis.

Zhang W, Xue F, Wang C, Shao L

Oncotarget 2018; (9(2)):2858-2865 doi:10.18632/oncotarget.23103.

No specific imaging pattern can help differentiate IgG4-related disease from idiopathic retroperitoneal fibrosis: 18 histologically proven cases.

Forestier A, Buob D, Mirault T, et al.

Clinical and experimental rheumatology 2018; (36(3)):371-375.

Rituximab for retroperitoneal fibrosis due to IgG4-related disease: A case report and literature review.

Almeqdadi M, Al-Dulaimi M, Perepletchikov A, et al.

Clinical nephrology. Case studies 2018; (6()):4-10 doi:10.5414/CNCS109321.

A case of IgG4-related kidney disease with predominantly unilateral renal atrophy.

Takeji A, Yamada K, Inoue D, et al.

CEN case reports 2019; (8(1)):8-13 doi:10.1007/s13730-018-0355-9.

Clinical Manifestations and Long-term Outcomes of IgG4-Related Kidney and Retroperitoneal Involvement in a United Kingdom IgG4-Related Disease Cohort.

Evans RDR, Cargill T, Goodchild G, et al.

Kidney international reports 2019; (4(1)):48-58 doi:10.1016/j.ekir.2018.08.011.

IgG4-related disease in patients with newly diagnosed idiopathic retroperitoneal fibrosis: a population-based Danish study.

Lomborg N, Jakobsen M, Bode CS, Junker P

Scandinavian journal of rheumatology 2019; (48(4)):320-325 doi:10.1080/03009742.2018.1551963.

Anterior hypopituitarism secondary to biopsy-proven IgG4-related hypophysitis in a young man.

Joshi H, Hikmat M, Devadass AP, et al.

Endocrinology, diabetes & metabolism case reports 2019; (2019()).

Retroperitoneal fibrosis: a rare disease for frontline clinicians.

Htet Z, Karim M

The journal of the Royal College of Physicians of Edinburgh 2019; (49(2)):125-127 doi:10.4997/JRCPE.2019.208.

Retrospective single-centre analysis of IgG4-related disease patient population and treatment outcomes between 2007 and 2017.

Lee CM, Alalwani M, Prayson RA, Gota CE

Rheumatology advances in practice 2019; (3(1)):rkz014 doi:10.1093/rap/rkz014.

The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease.

Wallace ZS, Naden RP, Chari S, et al.

Arthritis & rheumatology (Hoboken, N.J.) 2020; (72(1)):7-19 doi:10.1002/art.41120.

Immune mechanisms of fibrosis and inflammation in IgG4-related disease.

Pillai S, Perugino C, Kaneko N

Current opinion in rheumatology 2020; (32(2)):146-151 doi:10.1097/BOR.0000000000000686.

Differential Diagnosis: Retroperitoneal Fibrosis and Oncological Diseases.

Sica A, Casale B, Spada A, et al.

Open medicine (Warsaw, Poland) 2018; (15()):22-26 doi:10.1515/med-2020-0005.

Case report: IgG4-related renal disease co-existing with retroperitoneal fibrosis.

Kim YJ, Kim GE, Ma SK, et al.

Translational andrology and urology 2020; (9(2)):794-799 doi:10.21037/tau.2020.02.06.

Title not available

Le Joncour A, Saadoun D, Cacoub P

La Revue de medecine interne 2020; (41(12)):822-828 doi:10.1016/j.revmed.2020.06.013.

In vitro IL-6/IL-6R Trans-Signaling in Fibroblasts Releases Cytokines That May Be Linked to the Pathogenesis of IgG4-Related Disease.

Zongfei J, Rongyi C, Xiaomeng C, et al.

Frontiers in immunology 2020; (11()):1272 doi:10.3389/fimmu.2020.01272.

IgG4-related disease mimicking renal pelvis tumor with peritoneal carcinomatosis.

Chang CW, Tang SH, Su CH, et al.

Clinical case reports 2020; (8(10)):2040-2045 doi:10.1002/ccr3.3063.

IgG4 related disease as a cause of isolated retroperitoneal fibrosis with no other organ involvement; Case report.

Razok A, Malik R, Cackamvalli P, Zahid M

Annals of medicine and surgery (2012) 2021; (61()):69-72 doi:10.1016/j.amsu.2020.12.028.

Rapidly Progressive Kidney Failure Associated with Perirenal Capsular Lesion Due to IgG4-Related Disease.

Endo N, Shimizu H, Tanaka T, et al.

Internal medicine (Tokyo, Japan) 2021; (60(12)):1893-1897 doi:10.2169/internalmedicine.6232-20.

Peripheral TIGIT+ T Follicular Helper Cells That Produce High Levels of Interleukin-21 via OX40 Represent Disease Activity in IgG4-Related Disease.

Akiyama M, Suzuki K, Yoshimoto K, et al.

Frontiers in immunology 2021; (12()):651357 doi:10.3389/fimmu.2021.651357.

IgG4-related disease: an analysis of the clinicopathological spectrum: UK centre experience.

Dassanayaka W, Liyanaarachchi KS, Ala A, Bagwan IN

Journal of clinical pathology 2023; (76(1)):53-58 doi:10.1136/jclinpath-2021-207748.

An Interesting Case of Immunoglobulin G4-Related Retroperitoneal Fibrosis Treated With Rituximab.

Hamdan A, Moeen Z, Tariq H, et al.

Cureus 2021; (13(9)):e17940 doi:10.7759/cureus.17940.

IgG4-related retroperitoneal fibrosis: a rare cause of obstructive uropathy.

Krishna M, Parmar K, Kumar S, et al.

Annals of the Royal College of Surgeons of England 2022; (104(4)):e105-e108 doi:10.1308/rcsann.2021.0159.

Clinicopathological characteristics of IgG4-related lung disease.

Liu J, Liu Y, Shen X, et al.

BMC pulmonary medicine 2021; (21(1)):413 doi:10.1186/s12890-021-01781-3.

The function of IL-33/ST2 signaling axis in treg cells activating fibrosis in IgG4-related disease.

Wu Y, Liu J, Yu T, et al.

Human immunology 2022; (83(4)):295-305 doi:10.1016/j.humimm.2022.01.009.

Adolescent IgG4-related retroperitoneal fibrosis with left lower extremity edema as the first symptom: A case report.

Huang M, Yin Z

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 2021; (46(12)):1437-1441 doi:10.11817/j.issn.1672-7347.2021.200773.

Inferior vena cava thrombosis as the initial presentation of IgG4-related retroperitoneal fibrosis: Case report and literature review.

Simopoulou T, Klimopoulos S, Sampaziotis D, et al.

Journal of scleroderma and related disorders 2018; (3(3)):NP1-NP6 doi:10.1177/2397198318764793.

A 61-Year-Old Woman Presenting with Low Back Pain Diagnosed with IgG4-Related Disease Affecting the Thoracoabdominal Aorta and Retroperitoneum.

Kim MR, Shim H

The American journal of case reports 2022; (23()):e935007 doi:10.12659/AJCR.935007.

A case of IgG4-related retroperitoneal fibrosis with significant involvement of the abdominal aorta-a clinical and diagnostic challenge.

Gormley S, Bravo PT, Kos X, et al.

Journal of vascular surgery cases and innovative techniques 2022; (8(2)):275-280 doi:10.1016/j.jvscit.2022.02.003.

[IgG4-related disease of the breast].

Rybakova MG, Mylnikova AA, Vlasova MT

Arkhiv patologii 2022; (84(4)):51-55 doi:10.17116/patol20228404151.

Clinicopathological characteristics of gastric IgG4-related disease: Systematic scoping review.

Sawada H, Czech T, Silangcruz K, et al.

Journal of gastroenterology and hepatology 2022; (37(10)):1865-1872 doi:10.1111/jgh.15980.

Immune dysregulation in immunoglobulin G4-related disease.

Maehara T, Koga R, Nakamura S

The Japanese dental science review 2023; (59()):1-7 doi:10.1016/j.jdsr.2022.12.002.

IgG4-related retroperitoneal fibrosis with acute kidney injury: a case report and literature review.

Petelytska L, Nikitina A, Tarasenko O, et al.

Rheumatology international 2023; (43(11)):2141-2153 doi:10.1007/s00296-023-05402-6.

IgG4-related retroperitoneal fibrosis: A case report of a challenging disease.

Farook S, Jilani MSA, Islam MK, et al.

Clinical case reports 2023; (11(9)):e7865 doi:10.1002/ccr3.7865.

Systemic Involvement in Immunoglobulin G4-Related Ophthalmic Disease.

Lai KKH, Aljufairi FMAA, Sebastian JU, et al.

Ocular immunology and inflammation 2024; (32(8)):1852-1858 doi:10.1080/09273948.2023.2280709.

An Uncommon Expression of Immunoglobulin G4 (IgG4)-Related Disease: Sclerosing Mesenteritis Concomitant With IgG4-Related Autoimmune Pancreatitis.

Bennouna I, Bali MA, Gomez Galdon M, Veron Sanchez A

Cureus 2023; (15(12)):e50529 doi:10.7759/cureus.50529.

Management of IgG4-related disease.

Zhang W, Stone JH

The Lancet. Rheumatology 2019; (1(1)):e55-e65 doi:10.1016/S2665-9913(19)30017-7.

Validation of the Diagnostic Criteria for IgG4-Related Periaortitis/Periarteritis and Retroperitoneal Fibrosis (IgG4PA/RPF) 2018, and Proposal of a Revised 2023 Version for IgG4-Related Cardiovascular/Retroperitoneal Disease.

Mizushima I, Morikage N, Ito E, et al.

Circulation journal : official journal of the Japanese Circulation Society 2024; (88(10)):1679-1688 doi:10.1253/circj.CJ-24-0026.

Fibrotic phenotype of IgG4-related disease.

Lanzillotta M, Culver E, Sharma A, et al.

The Lancet. Rheumatology 2024; (6(7)):e469-e480 doi:10.1016/S2665-9913(23)00299-0.

Efficacy and safety of rituximab induction therapy and effect of rituximab maintenance for IgG4-related disease: a systematic review and meta-analysis.

Liu Y, Jin K, Yang Y, Yang A

European journal of internal medicine 2024; (127()):63-73 doi:10.1016/j.ejim.2024.06.006.

New insights into predictors of autoimmune pancreatitis relapse after steroid therapy.

Ujita W, Kamisawa T, Chiba K, et al.

Scandinavian journal of gastroenterology 2024; (59(10)):1202-1208 doi:10.1080/00365521.2024.2398771.

A protocol for targeted B-lymphocyte depletion for the treatment of IgG4-related disease.

Colquhoun M, Barwick TD, Bolton E, et al.

Rheumatology (Oxford, England) 2025; (64(5)):2847-2854 doi:10.1093/rheumatology/keae675.

Ormond's Disease - 26 Years of Experience at One Centre.

Průcha M, Zdráhal P, Kříž R, et al.

Prague medical report 2025; (126(1)):3-8 doi:10.14712/23362936.2025.1.

IgG4-related retroperitoneal fibrosis presenting as a peripancreatic mass: a case series.

Badshah MB, Khan QA, Kazi N, et al.

Annals of medicine and surgery (2012) 2025; (87(1)):36-42 doi:10.1097/MS9.0000000000002749.

Exploring the clinical characteristics and long-term outcome of serologically active clinically quiescent IgG4-related disease: knowledge from a prospective cohort.

Li J, Nie Y, Teng F, et al.

Clinical rheumatology 2025; (44(7)):2929-2940 doi:10.1007/s10067-025-07507-8.

Clinicopathological features of type 1 autoimmune pancreatitis without elevated serum IgG4 level.

Yamashita Y, Ishii Y, Hanada K, et al.

Scientific reports 2025; (15(1)):24518 doi:10.1038/s41598-025-10478-0.

[A CASE OF RENAL HILAR TUMORS IN IGG4-RELATED DISEASE].

Uehara K, Shibata Y, Washimi K, Osaka K

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 2024; (115(3)):134-137 doi:10.5980/jpnjurol.115.134.

Methotrexate and low-dose prednisone in idiopathic retroperitoneal fibrosis: a randomised clinical trial.

Peyronel F, Palmisano A, Maritati F, et al.

Journal of autoimmunity 2025; (157()):103487 doi:10.1016/j.jaut.2025.103487.

Clinicopathological Pearls and Diagnostic Pitfalls in IgG4-Related Disease: Challenging Case Series and Literature Review.

Sina S, Bonisoli GL, Vitale S, et al.

Diagnostics (Basel, Switzerland) 2025; (15(18)) doi:10.3390/diagnostics15182299.

IgG4-Related Disease: Endocrine Involvement, Clinical Implications, and Management Strategies.

Mohamed MA, Hammoud A, Jaber HM, et al.

Discoveries (Craiova, Romania) 2025; (13(4)):e219 doi:10.15190/d.2025.18.

IgG4-related Disease Affecting Multiple Organs Despite Normal Serum IgG4 Levels.

Kida T, Watanabe K, Nishikawa M, et al.

Internal medicine (Tokyo, Japan) 2026; doi:10.2169/internalmedicine.7062-25.